Literature DB >> 33320195

Tumor cell network integration in glioma represents a stemness feature.

Ruifan Xie1,2,3, Tobias Kessler1,2,4, Julia Grosch1,2, Ling Hai4,5,6, Varun Venkataramani1,2,7, Lulu Huang1,2, Dirk C Hoffmann2, Gergely Solecki1,2, Miriam Ratliff2,8, Matthias Schlesner4, Wolfgang Wick1,2, Frank Winkler1,2.   

Abstract

BACKGROUND: Malignant gliomas including glioblastomas are characterized by a striking cellular heterogeneity, which includes a subpopulation of glioma cells that becomes highly resistant by integration into tumor microtube (TM)-connected multicellular networks.
METHODS: A novel functional approach to detect, isolate, and characterize glioma cell subpopulations with respect to in vivo network integration is established, combining a dye staining method with intravital two-photon microscopy, Fluorescence-Activated Cell Sorting (FACS), molecular profiling, and gene reporter studies.
RESULTS: Glioblastoma cells that are part of the TM-connected tumor network show activated neurodevelopmental and glioma progression gene expression pathways. Importantly, many of them revealed profiles indicative of increased cellular stemness, including high expression of nestin. TM-connected glioblastoma cells also had a higher potential for reinitiation of brain tumor growth. Long-term tracking of tumor cell nestin expression in vivo revealed a stronger TM network integration and higher radioresistance of the nestin-high subpopulation. Glioblastoma cells that were both nestin-high and network-integrated were particularly able to adapt to radiotherapy with increased TM formation.
CONCLUSION: Multiple stem-like features are strongly enriched in a fraction of network-integrated glioma cells, explaining their particular resilience.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cancer stem cells; glioblastoma; glioma; networks; tumor microtubes

Mesh:

Substances:

Year:  2021        PMID: 33320195      PMCID: PMC8099480          DOI: 10.1093/neuonc/noaa275

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  34 in total

Review 1.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

2.  Harmful networks in the brain and beyond.

Authors:  Frank Winkler; Wolfgang Wick
Journal:  Science       Date:  2018-03-09       Impact factor: 47.728

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

5.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

6.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival.

Authors:  Zhe Zhu; Muhammad Amir Khan; Markus Weiler; Jonas Blaes; Leonie Jestaedt; Madeleine Geibert; Peng Zou; Jan Gronych; Olga Bernhardt; Andrey Korshunov; Verena Bugner; Peter Lichter; Bernhard Radlwimmer; Sabine Heiland; Martin Bendszus; Wolfgang Wick; Hai-Kun Liu
Journal:  Cell Stem Cell       Date:  2014-05-15       Impact factor: 24.633

8.  An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Authors:  Cyril Neftel; Julie Laffy; Mariella G Filbin; Toshiro Hara; Marni E Shore; Gilbert J Rahme; Alyssa R Richman; Dana Silverbush; McKenzie L Shaw; Christine M Hebert; John Dewitt; Simon Gritsch; Elizabeth M Perez; L Nicolas Gonzalez Castro; Xiaoyang Lan; Nicholas Druck; Christopher Rodman; Danielle Dionne; Alexander Kaplan; Mia S Bertalan; Julia Small; Kristine Pelton; Sarah Becker; Dennis Bonal; Quang-De Nguyen; Rachel L Servis; Jeremy M Fung; Ravindra Mylvaganam; Lisa Mayr; Johannes Gojo; Christine Haberler; Rene Geyeregger; Thomas Czech; Irene Slavc; Brian V Nahed; William T Curry; Bob S Carter; Hiroaki Wakimoto; Priscilla K Brastianos; Tracy T Batchelor; Anat Stemmer-Rachamimov; Maria Martinez-Lage; Matthew P Frosch; Ivan Stamenkovic; Nicolo Riggi; Esther Rheinbay; Michelle Monje; Orit Rozenblatt-Rosen; Daniel P Cahill; Anoop P Patel; Tony Hunter; Inder M Verma; Keith L Ligon; David N Louis; Aviv Regev; Bradley E Bernstein; Itay Tirosh; Mario L Suvà
Journal:  Cell       Date:  2019-07-18       Impact factor: 41.582

9.  Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.

Authors:  Xiaoyang Lan; David J Jörg; Florence M G Cavalli; Laura M Richards; Long V Nguyen; Robert J Vanner; Paul Guilhamon; Lilian Lee; Michelle M Kushida; Davide Pellacani; Nicole I Park; Fiona J Coutinho; Heather Whetstone; Hayden J Selvadurai; Clare Che; Betty Luu; Annaick Carles; Michelle Moksa; Naghmeh Rastegar; Renee Head; Sonam Dolma; Panagiotis Prinos; Michael D Cusimano; Sunit Das; Mark Bernstein; Cheryl H Arrowsmith; Andrew J Mungall; Richard A Moore; Yussanne Ma; Marco Gallo; Mathieu Lupien; Trevor J Pugh; Michael D Taylor; Martin Hirst; Connie J Eaves; Benjamin D Simons; Peter B Dirks
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

10.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  10 in total

1.  Short- and long-term efficacy of sustained-release chemotherapy in tumor bed interstitium combined with surgical resection for recurrent malignant glioma.

Authors:  Longlong Wang; Zhifeng Wang; Zan Liang; Guojing Li; Shibo Duan; Yanguo Xi
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 2.  The Network of Tumor Microtubes: An Improperly Reactivated Neural Cell Network With Stemness Feature for Resistance and Recurrence in Gliomas.

Authors:  Xinyue Wang; Jianhao Liang; Haitao Sun
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

Review 3.  3D imaging for driving cancer discovery.

Authors:  Ravian L van Ineveld; Esmée J van Vliet; Ellen J Wehrens; Maria Alieva; Anne C Rios
Journal:  EMBO J       Date:  2022-04-11       Impact factor: 14.012

Review 4.  Disconnecting multicellular networks in brain tumours.

Authors:  Varun Venkataramani; Matthias Schneider; Ulrich Herrlinger; Frank Winkler; Frank Anton Giordano; Thomas Kuner; Wolfgang Wick
Journal:  Nat Rev Cancer       Date:  2022-04-29       Impact factor: 69.800

5.  Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma.

Authors:  Matthias Schneider; Lea Vollmer; Anna-Laura Potthoff; Vidhya M Ravi; Bernd O Evert; Mohummad A Rahman; Shahin Sarowar; Jan Kueckelhaus; Paulina Will; David Zurhorst; Kevin Joseph; Julian P Maier; Nicolas Neidert; Paolo d'Errico; Melanie Meyer-Luehmann; Ulrich G Hofmann; Andreas Dolf; Paolo Salomoni; Erdem Güresir; Per Ø Enger; Martha Chekenya; Torsten Pietsch; Patrick Schuss; Oliver Schnell; Mike-Andrew Westhoff; Jürgen Beck; Hartmut Vatter; Andreas Waha; Ulrich Herrlinger; Dieter H Heiland
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 12.300

6.  Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma.

Authors:  Erik Jung; Matthias Osswald; Miriam Ratliff; Helin Dogan; Ruifan Xie; Sophie Weil; Dirk C Hoffmann; Felix T Kurz; Tobias Kessler; Sabine Heiland; Andreas von Deimling; Felix Sahm; Wolfgang Wick; Frank Winkler
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

7.  TGF-β promotes microtube formation in glioblastoma through thrombospondin 1.

Authors:  Justin V Joseph; Capucine R Magaut; Simon Storevik; Luiz H Geraldo; Thomas Mathivet; Md Abdul Latif; Justine Rudewicz; Joris Guyon; Matteo Gambaretti; Frida Haukas; Amalie Trones; Lars A Rømo Ystaas; Jubayer A Hossain; Sandra Ninzima; Sylvain Cuvellier; Wenjing Zhou; Tushar Tomar; Barbara Klink; Lalit Rane; Bronwyn K Irving; Joanne Marrison; Peter O'Toole; Heiko Wurdak; Jian Wang; Zhang Di; Even Birkeland; Frode S Berven; Frank Winkler; Frank A E Kruyt; Andreas Bikfalvi; Rolf Bjerkvig; Thomas Daubon; Hrvoje Miletic
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 12.300

Review 8.  Intercellular Communication in the Brain through Tunneling Nanotubes.

Authors:  Khattar E Khattar; Janice Safi; Anne-Marie Rodriguez; Marie-Luce Vignais
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

Review 9.  Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.

Authors:  Yahaya A Yabo; Simone P Niclou; Anna Golebiewska
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

10.  Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions.

Authors:  Silvana Valdebenito; Shaily Malik; Ross Luu; Olivier Loudig; Megan Mitchell; George Okafo; Krishna Bhat; Brendan Prideaux; Eliseo A Eugenin
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.